- Home
- SMTI vs XOMA Comparison
SMTI vs XOMA Comparison
Compare SMTI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- XOMA
- Stock Information
- Founded
- SMTI 1982
- XOMA 1981
- Country
- SMTI United States
- XOMA United States
- Employees
- SMTI N/A
- XOMA 13
- Industry
- SMTI Medical/Dental Instruments
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- XOMA Health Care
- Exchange
- SMTI Nasdaq
- XOMA Nasdaq
- Market Cap
- SMTI 273.6M
- XOMA 330.2M
- IPO Year
- SMTI N/A
- XOMA N/A
- Fundamental
- Price
- SMTI $28.58
- XOMA $25.82
- Analyst Decision
- SMTI Strong Buy
- XOMA Strong Buy
- Analyst Count
- SMTI 2
- XOMA 2
- Target Price
- SMTI $49.50
- XOMA $69.50
- AVG Volume (30 Days)
- SMTI 38.0K
- XOMA 71.2K
- Earning Date
- SMTI 08-11-2025
- XOMA 08-12-2025
- Dividend Yield
- SMTI N/A
- XOMA N/A
- EPS Growth
- SMTI N/A
- XOMA N/A
- EPS
- SMTI N/A
- XOMA N/A
- Revenue
- SMTI $91,569,883.00
- XOMA $42,909,000.00
- Revenue This Year
- SMTI $23.53
- XOMA $70.91
- Revenue Next Year
- SMTI $5.93
- XOMA $14.00
- P/E Ratio
- SMTI N/A
- XOMA N/A
- Revenue Growth
- SMTI 34.65
- XOMA 638.41
- 52 Week Low
- SMTI $25.86
- XOMA $18.35
- 52 Week High
- SMTI $39.08
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- SMTI 41.41
- XOMA 50.55
- Support Level
- SMTI $27.80
- XOMA $25.20
- Resistance Level
- SMTI $29.02
- XOMA $28.09
- Average True Range (ATR)
- SMTI 1.09
- XOMA 1.19
- MACD
- SMTI 0.08
- XOMA 0.06
- Stochastic Oscillator
- SMTI 32.96
- XOMA 42.92
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.